Epstein-Barr virus: An important vaccine target for cancer prevention

Jeffrey I. Cohen, Anthony S. Fauci, Harold Varmus, Gary J. Nabel

Research output: Contribution to journalArticle

Abstract

Participants at the February 2011 meeting at the U.S. National Institutes of Health on Epstein-Barr virus (EBV) vaccine research recommend that future clinical trials have two goals: prevention of infectious mononucleosis and EBV-associated cancers, facilitated by identification of disease-predictive surrogate markers.

Original languageEnglish (US)
Article number107fs7
JournalScience Translational Medicine
Volume3
Issue number107
DOIs
StatePublished - Nov 2 2011
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this